Economic Damages	12 Months Ended
Jun. 30, 2020
Commitments And Contingencies Disclosure [Abstract]
Economic Damages	13. ECONOMIC DAMAGES The Pharmacy segment subsidiary asserted claims for economic damages in connection with the Deepwater Horizon Settlement Program related to the event which occurred in 2010. In January 2018, these claims were settled and a payment of approximately $22 (net of costs and attorneys’ fees) for the year ended June 30, 2019 was received. The net settlement was recognized as a gain in the results for the year ended June 30, 2019.

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 30
-URI http://asc.fasb.org/subtopic&trid=2127197

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2127163

Name:	us-gaap_LossContingencyDisclosures
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration